Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome.

David C MetzEric LiuVijay N JoishLynn HuynhTodor I Totev Mei Sheng DuhKiernan SethSusan Giacalone Pablo LapuertaMichael A Morse

Published in: Cancer management and research (2020)

Patients showed improvements in clinical outcomes and indicators of overall health following treatment with telotristat ethyl in this exploratory pilot study, consistent with previously observed reductions in tumor size.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
public health
ionic liquid
prognostic factors
peritoneal dialysis
case report
patient reported outcomes
social media
risk assessment
combination therapy